BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10855937)

  • 1. Treatment of IgA nephropathy.
    Julian BA
    Semin Nephrol; 2000 May; 20(3):277-85. PubMed ID: 10855937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of IgA nephropathy: status at the end of the millenium.
    Glassock RJ
    J Nephrol; 1999; 12(5):288-96. PubMed ID: 10630691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of IgA nephropathy: an update.
    Rosselli JL; Thacker SM; Karpinski JP; Petkewicz KA
    Ann Pharmacother; 2011 Oct; 45(10):1284-96. PubMed ID: 21954446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fish oil therapy in IgA nephropathy.
    Fung SM; Ferrill MJ; Norton LL
    Ann Pharmacother; 1997 Jan; 31(1):112-5. PubMed ID: 8997477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of IgA nephropathy].
    Amoroso L; De Sanctis L; Cappelli P; Di Vito R; Sirolli V; Bonomini M
    G Ital Nefrol; 2011; 28(6):622-32. PubMed ID: 22167613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Berger's disease or primary IgA nephropathy in children].
    Renoult E; Cochat P; Jonon B; Kessler M
    Pediatrie; 1989; 44(5):365-74. PubMed ID: 2812962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of progressive IgA nephropathy: an update.
    Wang W; Chen N
    Contrib Nephrol; 2013; 181():75-83. PubMed ID: 23689569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors.
    Locatelli F; Vecchio LD; Pozzi C
    Nat Clin Pract Nephrol; 2006 Jan; 2(1):24-31. PubMed ID: 16932386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [IgA nephropathy. Significance of immunoglobulin A glycosylation in pathogenesis and clinical presentation].
    Matousovic K; Konecný K; Mĕstecký J; Tomana M; Novák J
    Cas Lek Cesk; 2002 Nov; 141(23):729-34. PubMed ID: 12650029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA nephropathy. From molecules to men.
    Tomino Y
    Contrib Nephrol; 1999; 126():III-IX, 1-115. PubMed ID: 10489630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H; Fujimoto S; Hara S; Sato Y; Yamada K; Eto T; Nakao H
    Ren Fail; 2005; 27(1):45-52. PubMed ID: 15717634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin A nephropathy: fish oils and beyond.
    Feehally J
    Curr Opin Nephrol Hypertens; 1996 Sep; 5(5):442-6. PubMed ID: 8937814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating the progression in IgA nephropathy.
    Chan JC; Trachtman H
    Nephron Clin Pract; 2006; 104(1):c61-8. PubMed ID: 16741372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of primary IgA nephropathy.
    Berthoux FC; Mohey H; Afiani A
    Semin Nephrol; 2008 Jan; 28(1):4-9. PubMed ID: 18222341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Present and future therapy options in IgA-nephropathy.
    Floege J; Eitner F
    J Nephrol; 2005; 18(4):354-61. PubMed ID: 16245237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA nephropathy and Henoch-Schönlein purpura nephritis.
    Sanders JT; Wyatt RJ
    Curr Opin Pediatr; 2008 Apr; 20(2):163-70. PubMed ID: 18332712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The usefulness of plasmapheresis in a case of nephrotic syndrome in Berger's disease].
    Pergolini M; Coppotelli L; Paradiso M; Mammarella A; Boccia P; Leonardo M; Basili S; Pettirossi G; Paoletti V; Cordova C
    Clin Ter; 1996 Nov; 147(11):543-7. PubMed ID: 9264907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
    Izzi C; Ravani P; Torres D; Prati E; Viola BF; Guerini S; Foramitti M; Frascà G; Amoroso A; Ghiggeri GM; Schena FP; Scolari F
    Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic IgA nephropathy: pathogenesis, histopathology, and therapeutic options.
    Tumlin JA; Madaio MP; Hennigar R
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):1054-61. PubMed ID: 17702711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.